IL1B and COVID-19: Even though poorly correlated to survival in COVID19 [27], especially IL-1β has been shown to decrease the beta-adrenergic responsiveness of L-type Ca2+ channels in a cAMP-independent mechanism, potentially decreasing cellular inotropic response [28].